CLINICAL TRIALS PROFILE FOR GALSULFASE
✉ Email this page to a colleague
All Clinical Trials for galsulfase
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00299000 ↗ | A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI | Completed | BioMarin Pharmaceutical | Phase 4 | 2006-05-01 | The purpose of the study is to evaluate the safety and efficacy of two dose levels of Naglazyme in infants under the age of one year who have MPS VI by monitoring physical appearance, x-ray of the skeletal system and growth. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for galsulfase
Condition Name
Clinical Trial Locations for galsulfase
Trials by Country
Clinical Trial Progress for galsulfase
Clinical Trial Phase
Clinical Trial Sponsors for galsulfase
Sponsor Name